Europe's pharma industry tried to prevent Greek drug pricing crisis hitting other countries
This article was originally published in Scrip
Executive Summary
Scrip has learnt that the body representing the European research-based pharmaceutical industry, EFPIA, tried to prevent the Greek drug pricing crisis of May 2010, which saw across-the-board drug price cuts of up to 27%, from affecting other countries in the European Union.